PRX-08066
- Generic Name
- PRX-08066
- Drug Type
- Small Molecule
- Chemical Formula
- C23H21ClFN5O4S
- Unique Ingredient Identifier
- 92E9B7675Y
- Indication
Investigated for use/treatment in chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00677872
- Locations
- 🇺🇸
Massachusetts General Hospital Pulmonary and Critical Care Unit, Boston, Massachusetts, United States
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Phase 2
Completed
- Conditions
- Pulmonary HypertensionChronic Obstructive Pulmonary Disease
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT00345774
- Locations
- 🇺🇸
Pulmonary Consultants of North Idaho, Coeur d'Alene, Idaho, United States
🇺🇸Central Medical Group, PA, Tamarac, Florida, United States
🇺🇸Buffalo Cardiology and Pulmonary Associates, P.C., Williamsville, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath